The Expression of Human Endogenous Retroviruses Is Modulated by the Tat Protein of HIV‐1

Total Page:16

File Type:pdf, Size:1020Kb

The Expression of Human Endogenous Retroviruses Is Modulated by the Tat Protein of HIV‐1 The Expression of Human Endogenous Retroviruses is modulated by the Tat protein of HIV‐1 by Marta Jeannette Gonzalez‐Hernandez A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy (Immunology) in The University of Michigan 2012 Doctoral Committee Professor David M. Markovitz, Chair Professor Gary Huffnagle Professor Michael J. Imperiale Associate Professor David J. Miller Assistant Professor Akira Ono Assistant Professor Christiane E. Wobus © Marta Jeannette Gonzalez‐Hernandez 2012 For my family and friends, the most fantastic teachers I have ever had. ii Acknowledgements First, and foremost, I would like to thank David Markovitz for his patience and his scientific and mentoring endeavor. My time in the laboratory has been an honor and a pleasure. Special thanks are also due to all the members of the Markovitz laboratory, past and present. It has been a privilege, and a lot of fun, to work near such excellent scientists and friends. You all have a special place in my heart. I would like to thank all the members of my thesis committee for all the valuable advice, help and jokes whenever needed. Our collaborators from the Bioinformatics Core, particularly James Cavalcoli, Fan Meng, Manhong Dai, Maureen Sartor and Gil Omenn gave generous support, technical expertise and scientific insight to a very important part of this project. Thank you. Thanks also go to Mariana Kaplan’s and Akira Ono’s laboratory for help with experimental designs and for being especially generous with time and reagents. iii Table of Contents Dedication ............................................................................................................................ ii Acknowledgements ............................................................................................................. iii List of Figures .................................................................................................................... viii List of Tables ........................................................................................................................ x Chapter I. Introduction Human Endogenous Retrovirus Type K (HML‐2) and HIV‐1 infection ............................................................................................ 1 Part I. Retroviruses and their General Properties ...................................... 1 A. Structure of Retroviruses a) General Properties ...................................................................... 4 b) Genomic Composition ................................................................ 6 Genome Organization ......................................................... 7 Long Terminal Repeats ....................................................... 8 c) Core Proteins Gag Protein ....................................................................... 10 Pol Protein‐Polymerase .................................................... 11 Pro Protein‐Protease......................................................... 12 Env Protein‐Envelope ........................................................ 12 Retroviral accesory proteins ............................................. 12 B. Replication of Retroviruses ................................................................... 13 iv C. Retroviral Classification ........................................................................ 14 Part II. Human Endogenous Retroviruses (HERVs) ................................... 17 A. General properties of HERVs ................................................................ 17 B. Classification of HERVs .......................................................................... 20 Class I HERVs ................................................................................. 21 Class II HERVs ................................................................................ 22 Class III HERVs ............................................................................... 23 C. HERV expression within Humans .......................................................... 23 D. Pathological Role of HERVs ................................................................... 28 E. Human Endogenous Retrovirus Type K (HML‐2) ............................................. 31 Part III. Human Endogenous Retrovirus Type K and HIV‐1 infection ....... 36 A. Expression of HERV‐K (HML‐2) during HIV‐1 infection ......................... 36 B. Mechanism of activation of HERV‐K (HML‐2) during HIV‐1 infection ............. 37 Thesis Focus and Hypothesis .................................................................... 40 II. Expression of Human Endogenous Retrovirus Type K (HML‐2) is activated by the Tat protein of HIV‐1 ....................................................... 42 Abstract ..................................................................................................... 42 Introduction .............................................................................................. 43 HERV‐K (HML‐2) RNA expression is increased in HIV‐1‐infected cell lines .......... 47 HIV‐1 Tat and Vif independently cause an increase in HERV‐K (HML‐2) gag RNA expression ............................................................................................. 50 Recombinant HIV‐1 Tat increases HERV‐K (HML‐2) expression ............... 54 Activation of the HERV‐K (HML‐2) promoter by HIV‐1 Tat ....................... 61 Activation of the HERV‐K (HML‐2) promoter by Tat is mediated by NF‐κB and NF‐AT ....................................................................................... 65 Discussion.................................................................................................. 76 v Materials and Methods ............................................................................. 80 III. HIV‐1 Tat causes the activation of a novel centromeric Human Endogenous Retrovirus Type K (HML‐2) discovered through HIV infection ............................ 93 Abstract ..................................................................................................... 93 Introduction .............................................................................................. 94 A new HERV‐K (HML‐2) virus, K111, is discovered in the plasma of HIV‐1‐infected individuals and is only activated during HIV‐1 infection ........ 96 In vitro infection of cell lines with HIV‐1 causes expression of K111 ....... 99 HIV‐1 Tat induces the expression of K111 from centromeric regions through chromatin remodeling .............................................................. 101 Discussion................................................................................................ 105 Materials and Methods ........................................................................... 107 IV. The HERV‐K (HML‐2) transcriptome induced by the HIV‐1 Tat protein .............................................................................................. 114 Abstract ................................................................................................... 114 Introduction ............................................................................................ 115 HIV‐1 Tat both activates and silences specific HERV‐K (HML‐2) proviruses in normal PBLs ....................................................................... 120 HIV‐1 Tat both activates and silences specific HERV‐K (HML‐2) proviruses in normal PBLs ....................................................................... 120 qPCR validation of specific HERV‐K (HML‐2) provirus activation and silencing by HIV‐1 Tat corroborates RNA‐Seq data analysis ................... 128 Nature of the HERV‐K (HML‐2) Tat‐activated transcripts ....................... 132 vi Most of the Tat‐induced HERV‐K (HML‐2) proviruses are Type 2, yet do not contain ORFs ................................................................................ 133 Correlation of HERV‐K (HML‐2) proviruses activated by Tat to those detected in the plasma of HIV‐1‐infected patients ................................ 136 Discussion................................................................................................ 138 Materials and Methods ........................................................................... 140 V. Conclusions ………………………………………………………………………………………..146 HERV‐K (HML‐2) and HIV‐1 Tat ............................................................... 150 Future explorations: testing the consequences of increased HERV‐K (HML‐2) expression ................................................................................. 152 Appendix ......................................................................................................................... 158 Bibliography .................................................................................................................... 165 vii List of Figures Figure Page 1.1 Basic structure of the retroviral virion. 4 1.2 Organization of the retroviral genome. 6 1.3 Proviral Genome and LTR. 10 1.4 Basic retroviral lifecycle. 14 2.1 HIV‐1 infection and Tat stimulate HERV‐K (HML‐2) gene expression. 49 2.2 HIV‐1 Tat and Vif proteins activate HERV‐K (HML‐2) RNA expression. 52 2.3 Recombinant HIV‐1 Tat activates HERV‐K (HML‐2) gene expression. 58 2.4 HIV‐1 Tat activates the HERV‐K (HML‐2) promoter by a different mechanism than it uses to activate HIV‐1. 63 2.5 Inhibition of the NF‐κB or NF‐AT transcription factors suppresses Tat‐mediated activation from the HERV‐K (HML‐2) LTR. 69 2.6 Tat responsive elements
Recommended publications
  • Non-Primate Lentiviral Vectors and Their Applications in Gene Therapy for Ocular Disorders
    viruses Review Non-Primate Lentiviral Vectors and Their Applications in Gene Therapy for Ocular Disorders Vincenzo Cavalieri 1,2,* ID , Elena Baiamonte 3 and Melania Lo Iacono 3 1 Department of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, Viale delle Scienze Edificio 16, 90128 Palermo, Italy 2 Advanced Technologies Network (ATeN) Center, University of Palermo, Viale delle Scienze Edificio 18, 90128 Palermo, Italy 3 Campus of Haematology Franco e Piera Cutino, Villa Sofia-Cervello Hospital, 90146 Palermo, Italy; [email protected] (E.B.); [email protected] (M.L.I.) * Correspondence: [email protected] Received: 30 April 2018; Accepted: 7 June 2018; Published: 9 June 2018 Abstract: Lentiviruses have a number of molecular features in common, starting with the ability to integrate their genetic material into the genome of non-dividing infected cells. A peculiar property of non-primate lentiviruses consists in their incapability to infect and induce diseases in humans, thus providing the main rationale for deriving biologically safe lentiviral vectors for gene therapy applications. In this review, we first give an overview of non-primate lentiviruses, highlighting their common and distinctive molecular characteristics together with key concepts in the molecular biology of lentiviruses. We next examine the bioengineering strategies leading to the conversion of lentiviruses into recombinant lentiviral vectors, discussing their potential clinical applications in ophthalmological research. Finally, we highlight the invaluable role of animal organisms, including the emerging zebrafish model, in ocular gene therapy based on non-primate lentiviral vectors and in ophthalmology research and vision science in general. Keywords: FIV; EIAV; BIV; JDV; VMV; CAEV; lentiviral vector; gene therapy; ophthalmology; zebrafish 1.
    [Show full text]
  • Chapitre Quatre La Spécificité D'hôtes Des Virophages Sputnik
    AIX-MARSEILLE UNIVERSITE FACULTE DE MEDECINE DE MARSEILLE ECOLE DOCTORALE DES SCIENCES DE LA VIE ET DE LA SANTE THESE DE DOCTORAT Présentée par Morgan GAÏA Né le 24 Octobre 1987 à Aubagne, France Pour obtenir le grade de DOCTEUR de l’UNIVERSITE AIX -MARSEILLE SPECIALITE : Pathologie Humaine, Maladies Infectieuses Les virophages de Mimiviridae The Mimiviridae virophages Présentée et publiquement soutenue devant la FACULTE DE MEDECINE de MARSEILLE le 10 décembre 2013 Membres du jury de la thèse : Pr. Bernard La Scola Directeur de thèse Pr. Jean -Marc Rolain Président du jury Pr. Bruno Pozzetto Rapporteur Dr. Hervé Lecoq Rapporteur Faculté de Médecine, 13385 Marseille Cedex 05, France URMITE, UM63, CNRS 7278, IRD 198, Inserm 1095 Directeur : Pr. Didier RAOULT Avant-propos Le format de présentation de cette thèse correspond à une recommandation de la spécialité Maladies Infectieuses et Microbiologie, à l’intérieur du Master des Sciences de la Vie et de la Santé qui dépend de l’Ecole Doctorale des Sciences de la Vie de Marseille. Le candidat est amené à respecter des règles qui lui sont imposées et qui comportent un format de thèse utilisé dans le Nord de l’Europe permettant un meilleur rangement que les thèses traditionnelles. Par ailleurs, la partie introduction et bibliographie est remplacée par une revue envoyée dans un journal afin de permettre une évaluation extérieure de la qualité de la revue et de permettre à l’étudiant de commencer le plus tôt possible une bibliographie exhaustive sur le domaine de cette thèse. Par ailleurs, la thèse est présentée sur article publié, accepté ou soumis associé d’un bref commentaire donnant le sens général du travail.
    [Show full text]
  • Anthropoid Primate–Specific Retroviral Element THE1B Controls Expression of CRH in Placenta and Alters Gestation Length
    SHORT REPORTS Anthropoid primate±specific retroviral element THE1B controls expression of CRH in placenta and alters gestation length 1 1 1 2 Caitlin E. Dunn-FletcherID *, Lisa M. Muglia , Mihaela Pavlicev , Gernot Wolf , Ming- An Sun2, Yueh-Chiang Hu3, Elizabeth Huffman1, Shivani Tumukuntala1, Katri Thiele1, Amrita Mukherjee1, Sandra Zoubovsky1, Xuzhe Zhang1, Kayleigh A. Swaggart1, Katherine Y. Bezold Lamm1, Helen Jones4, Todd S. Macfarlan2, Louis J. Muglia1* a1111111111 1 Division of Human Genetics, Center for Prevention of Preterm Birth, Perinatal Institute, Cincinnati a1111111111 Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, a1111111111 Cincinnati, Ohio, United States of America, 2 The Eunice Kennedy Shriver National Institute of Child Health a1111111111 and Human Development, The National Institutes of Health, Bethesda, Maryland, United States of America, 3 Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Department of a1111111111 Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, United States of America, 4 Division of Pediatric Surgery, Cincinnati Children's Hospital Medical Center, Department of Surgery, University of Cincinnati College of Medicine, Cincinnati, Ohio, United States of America * [email protected] (CED); [email protected] (LJM) OPEN ACCESS Citation: Dunn-Fletcher CE, Muglia LM, Pavlicev M, Wolf G, Sun M-A, Hu Y-C, et al. (2018) Anthropoid Abstract primate±specific retroviral element THE1B controls expression of CRH in placenta and alters gestation Pregnancy and parturition are intricately regulated to ensure successful reproductive out- length. PLoS Biol 16(9): e2006337. https://doi.org/ comes. However, the factors that control gestational length in humans and other anthropoid 10.1371/journal.pbio.2006337 primates remain poorly defined.
    [Show full text]
  • Alpha-Satellite RNA Transcripts Are Repressed by Centromere
    RESEARCH ARTICLE Alpha-satellite RNA transcripts are repressed by centromere–nucleolus associations Leah Bury1†, Brittania Moodie1†, Jimmy Ly1,2, Liliana S McKay1, Karen HH Miga3, Iain M Cheeseman1,2* 1Whitehead Institute for Biomedical Research, Cambridge, United States; 2Department of Biology, Massachusetts Institute of Technology, Cambridge, United States; 3UC Santa Cruz Genomics Institute, University of California, Santa Cruz, Santa Cruz, United States Abstract Although originally thought to be silent chromosomal regions, centromeres are instead actively transcribed. However, the behavior and contributions of centromere-derived RNAs have remained unclear. Here, we used single-molecule fluorescence in-situ hybridization (smFISH) to detect alpha-satellite RNA transcripts in intact human cells. We find that alpha-satellite RNA- smFISH foci levels vary across cell lines and over the cell cycle, but do not remain associated with centromeres, displaying localization consistent with other long non-coding RNAs. Alpha-satellite expression occurs through RNA polymerase II-dependent transcription, but does not require established centromere or cell division components. Instead, our work implicates centromere– nucleolar interactions as repressing alpha-satellite expression. The fraction of nucleolar-localized centromeres inversely correlates with alpha-satellite transcripts levels across cell lines and transcript levels increase substantially when the nucleolus is disrupted. The control of alpha-satellite transcripts by centromere-nucleolar contacts provides a mechanism to modulate centromere transcription and chromatin dynamics across diverse cell states and conditions. *For correspondence: [email protected] †These authors contributed equally to this work Introduction Chromosome segregation requires the function of a macromolecular kinetochore structure to con- Competing interests: The nect chromosomal DNA and spindle microtubule polymers.
    [Show full text]
  • Advances in the Study of Transmissible Respiratory Tumours in Small Ruminants Veterinary Microbiology
    Veterinary Microbiology 181 (2015) 170–177 Contents lists available at ScienceDirect Veterinary Microbiology journa l homepage: www.elsevier.com/locate/vetmic Advances in the study of transmissible respiratory tumours in small ruminants a a a a,b a, M. Monot , F. Archer , M. Gomes , J.-F. Mornex , C. Leroux * a INRA UMR754-Université Lyon 1, Retrovirus and Comparative Pathology, France; Université de Lyon, France b Hospices Civils de Lyon, France A R T I C L E I N F O A B S T R A C T Sheep and goats are widely infected by oncogenic retroviruses, namely Jaagsiekte Sheep RetroVirus (JSRV) Keywords: and Enzootic Nasal Tumour Virus (ENTV). Under field conditions, these viruses induce transformation of Cancer differentiated epithelial cells in the lungs for Jaagsiekte Sheep RetroVirus or the nasal cavities for Enzootic ENTV Nasal Tumour Virus. As in other vertebrates, a family of endogenous retroviruses named endogenous Goat JSRV Jaagsiekte Sheep RetroVirus (enJSRV) and closely related to exogenous Jaagsiekte Sheep RetroVirus is present Lepidic in domestic and wild small ruminants. Interestingly, Jaagsiekte Sheep RetroVirus and Enzootic Nasal Respiratory infection Tumour Virus are able to promote cell transformation, leading to cancer through their envelope Retrovirus glycoproteins. In vitro, it has been demonstrated that the envelope is able to deregulate some of the Sheep important signaling pathways that control cell proliferation. The role of the retroviral envelope in cell transformation has attracted considerable attention in the past years, but it appears to be highly dependent of the nature and origin of the cells used. Aside from its health impact in animals, it has been reported for many years that the Jaagsiekte Sheep RetroVirus-induced lung cancer is analogous to a rare, peculiar form of lung adenocarcinoma in humans, namely lepidic pulmonary adenocarcinoma.
    [Show full text]
  • Detection of HERV‑K6 and HERV‑K11 Transpositions in the Human Genome
    BIOMEDICAL REPORTS 9: 53-59, 2018 Detection of HERV‑K6 and HERV‑K11 transpositions in the human genome BUKET CAKMAK GUNER1, ELIF KARLIK2, SEVGI MARAKLI1 and NERMIN GOZUKIRMIZI1 1Department of Molecular Biology and Genetics, Faculty of Science, Istanbul University, 34134 Istanbul; 2Department of Biotechnology, Institution of Science, Istanbul University, 34134 Istanbul, Turkey Received November 19, 2017; Accepted April 24, 2018 DOI: 10.3892/br.2018.1096 Abstract. Mobile genetic elements classed as transposons analysed HERV‑K movements among individuals. This is the comprise an estimated 45% of the human genome, and 8% of first report to investigate HERV‑K6 and HERV‑K11 retrotrans- these elements are human endogenous retroviruses (HERVs). poson polymorphisms between the genders and different age Endogenous retroviruses are retrotransposons, containing 5' groups. and 3' long terminal repeat sequences and encoding envelope, group‑specific antigen and DNA polymerase proteins. The Introduction aim of the present study was to analyse genome integration polymorphisms of HERV type K member 6 (HERV‑K6) and Human endogenous retroviruses (HERVs) belonging to the HERV‑K11 by using the retrotransposon based molecular superfamily of transposable and retrotransposable genetic marker technique, inter‑retrotransposon amplified polymor- elements represent ~8% of the human genome (1). HERV phism (IRAP). For this purpose, blood samples of 18 healthy type K (HERV‑K) is the sole group of endogenous retroviruses individuals within the age range of 10‑79 years (10 females that is established to contain human‑specific members. Group and 8 males) were collected, genomic DNAs were isolated HERV‑K (also known as human mouse mammary tumour and IRAP‑polymerase chain reaction (PCR) was performed.
    [Show full text]
  • Ervmap Analysis Reveals Genome-Wide Transcription of INAUGURAL ARTICLE Human Endogenous Retroviruses
    ERVmap analysis reveals genome-wide transcription of INAUGURAL ARTICLE human endogenous retroviruses Maria Tokuyamaa, Yong Konga, Eric Songa, Teshika Jayewickremea, Insoo Kangb, and Akiko Iwasakia,c,1 aDepartment of Immunobiology, Yale School of Medicine, New Haven, CT 06520; bDepartment of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520; and cHoward Hughes Medical Institute, Chevy Chase, MD 20815 This contribution is part of the special series of Inaugural Articles by members of the National Academy of Sciences elected in 2018. Contributed by Akiko Iwasaki, October 23, 2018 (sent for review August 24, 2018; reviewed by Stephen P. Goff and Nir Hacohen) Endogenous retroviruses (ERVs) are integrated retroviral elements regulates expression of IFN-γ–responsive genes, such as AIM2, that make up 8% of the human genome. However, the impact of APOL1, IFI6, and SECTM1 (16). ERV elements can drive ERVs on human health and disease is not well understood. While transcription of genes, generate chimeric transcripts with protein- select ERVs have been implicated in diseases, including autoim- coding genes in cancer, serve as splice donors or acceptors mune disease and cancer, the lack of tools to analyze genome- for neighboring genes, and be targets of recombination and in- wide, locus-specific expression of proviral autonomous ERVs has crease genomic diversity (17, 18). ERVs that are elevated in hampered the progress in the field. Here we describe a method breast cancer tissues correlate with the expression of granzyme called ERVmap, consisting of an annotated database of 3,220 hu- and perforin levels, implying a possible role of ERVs in immune man proviral ERVs and a pipeline that allows for locus-specific surveillance of tumors (19).
    [Show full text]
  • HIV 101: Pathogenesis and Treatment
    HIV 101: Pathogenesis and Treatment Stephen Raffanti MD MPH Professor of Medicine Vanderbilt University School of Medicine . Dr. Raffanti has no financial disclosures to make. Objectives . After this presentation the attendee should be able to: . Describe current issues in the epidemiology of the HIV epidemic. Describe the life cycle of HIV; . Describe the way that HIV interacts with its host, producing disease. Describe the principles of treatment. Describe Acute HIV infection . Describe the initial evaluation of an HIV infected patient Testing, linkage to care, effective treatment and effective PrEP could stop the epidemic today. Percentages of Diagnoses of HIV Infection among Adults and Adolescents, by Region and Population of Area of Residence, 2015—United States Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis. Data for the year 2015 are preliminary and based on 6 months reporting delay. Data exclude persons whose county of residence is unknown. Percentages of Diagnoses of HIV Infection among Adults and Adolescents, by Population of Area of Residence and Age at Diagnosis, 2015—United States Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis. Data for the year 2015 are preliminary and based on 6 months reporting delay. Data exclude persons whose county of residence is unknown. Diagnoses of HIV Infection among Men Who Have Sex with Men, by Age Group, 2010–2014—United States and 6 Dependent Areas Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis. All displayed data have been statistically adjusted to account for reporting delays and missing transmission category, but not for incomplete reporting.
    [Show full text]
  • Characteristics of Virophages and Giant Viruses Beata Tokarz-Deptuła1*, Paulina Czupryńska2, Agata Poniewierska-Baran1 and Wiesław Deptuła2
    Vol. 65, No 4/2018 487–496 https://doi.org/10.18388/abp.2018_2631 Review Characteristics of virophages and giant viruses Beata Tokarz-Deptuła1*, Paulina Czupryńska2, Agata Poniewierska-Baran1 and Wiesław Deptuła2 1Department of Immunology, 2Department of Microbiology, Faculty of Biology, University of Szczecin, Szczecin, Poland Five years after being discovered in 2003, some giant genus, Mimiviridae family (Table 3). It was found in the viruses were demonstrated to play a role of the hosts protozoan A. polyphaga in a water-cooling tower in Brad- for virophages, their parasites, setting out a novel and ford (Table 1). Sputnik has a spherical dsDNA genome yet unknown regulatory mechanism of the giant virus- closed in a capsid with icosahedral symmetry, 50–74 nm es presence in an aqueous. So far, 20 virophages have in size, inside which there is a lipid membrane made of been registered and 13 of them have been described as phosphatidylserine, which probably protects the genetic a metagenomic material, which indirectly impacts the material of the virophage (Claverie et al., 2009; Desnues number of single- and multi-cell organisms, the environ- et al., 2012). Sputnik’s genome has 18343 base pairs with ment where giant viruses replicate. 21 ORFs that encode proteins of 88 to 779 amino ac- ids. They compose the capsids and are responsible for Key words: virophages, giant viruses, MIMIVIRE, Sputnik N-terminal acetylation of amino acids and transposases Received: 14 June, 2018; revised: 21 August, 2018; accepted: (Claverie et al., 2009; Desnues et al., 2012; Tokarz-Dep- 09 September, 2018; available on-line: 23 October, 2018 tula et al., 2015).
    [Show full text]
  • VMC 321: Systematic Veterinary Virology Retroviridae Retro: from Latin Retro,"Backwards”
    VMC 321: Systematic Veterinary Virology Retroviridae Retro: from Latin retro,"backwards” - refers to the activity of reverse RETROVIRIDAE transcriptase and the transfer of genetic information from RNA to DNA. Retroviruses Viral RNA Viral DNA Viral mRNA, genome (integrated into host genome) Reverse (retro) transfer of genetic information Usually, well adapted to their hosts Endogenous retroviruses • RNA viruses • single stranded, positive sense, enveloped, icosahedral. • Distinguished from all other RNA viruses by presence of an unusual enzyme, reverse transcriptase. Retroviruses • Retro = reversal • RNA is serving as a template for DNA synthesis. • One genera of veterinary interest • Alpharetrovirus • • Family - Retroviridae • Subfamily - Orthoretrovirinae [Ortho: from Greek orthos"straight" • Genus -. Alpharetrovirus • Genus - Betaretrovirus Family- • Genus - Gammaretrovirus • Genus - Deltaretrovirus Retroviridae • Genus - Lentivirus [ Lenti: from Latin lentus, "slow“ ]. • Genus - Epsilonretrovirus • Subfamily - Spumaretrovirinae • Genus - Spumavirus Retroviridae • Subfamily • Orthoretrovirinae • Genus • Alpharetrovirus Alpharetrovirus • Species • Avian leukosis virus(ALV) • Rous sarcoma virus (RSV) • Avian myeloblastosis virus (AMV) • Fujinami sarcoma virus (FuSV) • ALVs have been divided into 10 envelope subgroups - A , B, C, D, E, F, G, H, I & J based on • host range Avian • receptor interference patterns • neutralization by antibodies leukosis- • subgroup A to E viruses have been divided into two groups sarcoma • Noncytopathic (A, C, and E) • Cytopathic (B and D) virus (ALV) • Cytopathic ALVs can cause a transient cytotoxicity in 30- 40% of the infected cells 1. The viral envelope formed from host cell membrane; contains 72 spiked knobs. 2. These consist of a transmembrane protein TM (gp 41), which is linked to surface protein SU (gp 120) that binds to a cell receptor during infection. 3. The virion has cone-shaped, icosahedral core, Structure containing the major capsid protein 4.
    [Show full text]
  • Effects of Retroviruses on Host Genome Function
    ANRV361-GE42-20 ARI 1 August 2008 18:2 V I E E W R S I E N C N A D V A Effects of Retroviruses on Host Genome Function Patric Jern and John M. Coffin Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts 02111; email: [email protected], John.Coffi[email protected] Annu. Rev. Genet. 2008. 42:20.1–20.23 Key Words The Annual Review of Genetics is online at Human Endogenous Retrovirus, LTR, transcription, recombination, genet.annualreviews.org methylation This article’s doi: 10.1146/annurev.genet.42.110807.091501 Abstract Copyright c 2008 by Annual Reviews. For millions of years, retroviral infections have challenged vertebrates, All rights reserved occasionally leading to germline integration and inheritance as ERVs, 0066-4197/08/1201-0001$20.00 genetic parasites whose remnants today constitute some 7% to 8% of the human genome. Although they have had significant evolutionary side effects, it is useful to view ERVs as fossil representatives of retro- viruses extant at the time of their insertion into the germline, not as direct players in the evolutionary process itself. Expression of particu- lar ERVs is associated with several positive physiological functions as well as certain diseases, although their roles in human disease as etio- logical agents, possible contributing factors, or disease markers—well demonstrated in animal models—remain to be established. Here we discuss ERV contributions to host genome structure and function, in- cluding their ability to mediate recombination, and physiological effects on the host transcriptome resulting from their integration, expression, and other events.
    [Show full text]
  • Lentiviral Integration Site Targeting: Host Determinants and Consequences
    University of Pennsylvania ScholarlyCommons Publicly Accessible Penn Dissertations Spring 2010 Lentiviral Integration Site Targeting: Host Determinants and Consequences Keshet Ronen University of Pennsylvania, [email protected] Follow this and additional works at: https://repository.upenn.edu/edissertations Part of the Virology Commons Recommended Citation Ronen, Keshet, "Lentiviral Integration Site Targeting: Host Determinants and Consequences" (2010). Publicly Accessible Penn Dissertations. 174. https://repository.upenn.edu/edissertations/174 This paper is posted at ScholarlyCommons. https://repository.upenn.edu/edissertations/174 For more information, please contact [email protected]. Lentiviral Integration Site Targeting: Host Determinants and Consequences Abstract A necessary step in the retroviral lifecycle is integration, the covalent insertion of the viral cDNA into the genome of the infected cell. This means that retroviruses, for example HIV, establish life-long infection. It also means that retroviruses are used as gene-delivery vectors to treat genetic diseases. Integration events are distributed non-randomly in the genome of the infected cell, with characteristic genus-specific preferences. In this dissertation, we focus on the lentiviral class of retroviruses, and explore two aspects of their integration: the means by which integration is targeted to its favored sites, and the consequences of integration at these sites for the host cell. The host protein LEDGF/p75 has been shown to interact with lentiviral integrases and contribute to their preference for integration in genes. We sought to establish the extent to which integration site selection is determined by LEDGF/p75 tethering. We first asked whether LEDGF/p75 was an essential integration tether, by analyzing integration site distribution in cells stringently depleted for LEDGF/p75.
    [Show full text]